Efficacy and tolerability of Blonanserin in the patients with schizophrenia: a randomized, double-blind, risperidone-compared trial.
about
Profile of blonanserin for the treatment of schizophreniaEffect of blonanserin on cognitive function in antipsychotic-naïve first-episode schizophrenia.Population pharmacokinetics of blonanserin in Chinese healthy volunteers and the effect of the food intake.Almost all antipsychotics result in weight gain: a meta-analysis.Japan useful medication program for schizophrenia (JUMPs)-long-term study on discontinuation rate, resolution and remission, and improvement in social functioning rate associated with atypical antipsychotic medications in patients with schizophreniaTargeting the dopamine receptor in schizophrenia: investigational drugs in Phase III trials.Cardiometabolic risks of blonanserin and perospirone in the management of schizophrenia: a systematic review and meta-analysis of randomized controlled trials.One-Year Follow-Up of Serum Prolactin Level in Schizophrenia Patients Treated with Blonanserin: A Case Series.Blonanserin - A Novel Antianxiety and Antidepressant Drug? An Experimental Study.Newer antipsychotics and upcoming molecules for schizophrenia.Blonanserin-induced Mood Alteration in Schizophrenia and Schizoaffective Disorder: Two Cases.Simple and sensitive analysis of blonanserin and blonanserin C in human plasma by liquid chromatography tandem mass spectrometry and its application.Blonanserin Augmentation of Atypical Antipsychotics in Patients with Schizophrenia-Who Benefits from Blonanserin Augmentation?: An Open-Label, Prospective, Multicenter Study.Early prediction of blonanserin response in Japanese patients with schizophrenia.Long-term efficacy and safety of blonanserin in patients with first-episode schizophrenia: a 1-year open-label trial.One-year follow-up study of psychotic patients treated with blonanserin: a case series.The Differential Binding of Antipsychotic Drugs to the ABC Transporter P-Glycoprotein Predicts Cannabinoid-Antipsychotic Drug Interactions.Early referral and comorbidity as possible causes of the declining transition rate in subjects at clinical high risk for psychosis.The relationship between the plasma concentration of blonanserin, and its plasma anti-serotonin 5-HT(2A) activity/anti-dopamine D₂ activity ratio and drug-induced extrapyramidal symptoms.Psychotic mania as the solitary manifestation of neurosyphilis.
P2860
Q24614169-6A39A577-96AF-491A-8869-595285719106Q34249753-33CE66F3-9975-48AE-A153-EC9531D59FA3Q34328266-5B5B7B2B-9F94-4438-8BE3-0B0CF97FABF0Q34661499-95650C83-D1E8-48B1-B4C8-E654FC070036Q35007214-5634B8C4-C330-4837-8EE3-AA6E4CA85CCAQ35071909-F34BE086-F595-4D6D-A82C-B1CE7683B82BQ35088447-C916A99A-C356-4A98-A939-B8E46593D070Q36205458-E5F300A4-8C4F-43AD-B843-E9C704396117Q37352996-F0CD7C9C-63E0-4839-A141-7BBC9A89B1C0Q38094930-2B666B48-4B10-4A2E-9A95-7A9D8CC0DEF9Q41883062-11C1E2EF-0123-4085-B5C4-FBF157EF005BQ41997913-A74A0DA5-4943-47E4-B63D-7A94782964C5Q42395373-E97402D4-AEEA-4EB2-BD6C-E57A3662ECB8Q42924056-E601299C-38BB-43D5-B43C-DE5CD070088FQ48076232-B0B5440C-FD6D-42D8-B52F-2367029E44EAQ48205983-EC4399EA-64A1-441F-9955-F7E43F797309Q48273932-AFA9A508-A913-4C51-82CC-B00CAABBA881Q48527862-E3A10688-CC54-406E-9F94-6F548B965EDBQ50516552-C3635EED-3479-4FC4-B069-3CE184DF4526Q55205969-44F4F4D4-6213-4BB6-97B6-FCCA29360966
P2860
Efficacy and tolerability of Blonanserin in the patients with schizophrenia: a randomized, double-blind, risperidone-compared trial.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Efficacy and tolerability of B ...... d, risperidone-compared trial.
@ast
Efficacy and tolerability of B ...... d, risperidone-compared trial.
@en
Efficacy and tolerability of B ...... d, risperidone-compared trial.
@nl
type
label
Efficacy and tolerability of B ...... d, risperidone-compared trial.
@ast
Efficacy and tolerability of B ...... d, risperidone-compared trial.
@en
Efficacy and tolerability of B ...... d, risperidone-compared trial.
@nl
prefLabel
Efficacy and tolerability of B ...... d, risperidone-compared trial.
@ast
Efficacy and tolerability of B ...... d, risperidone-compared trial.
@en
Efficacy and tolerability of B ...... d, risperidone-compared trial.
@nl
P2093
P1476
Efficacy and tolerability of B ...... d, risperidone-compared trial.
@en
P2093
Bo-Hyun Yoon
Chan-Hyung Kim
Duk-In Jon
Hee-Cheol Kim
Hee-Yeon Jung
Hyun-Sang Cho
Jaewon Yang
Jun-Soo Kwon
Jung-Seo Yi
Sang-Yeol Lee
P304
P356
10.1097/WNF.0B013E3181DCDA50
P577
2010-07-01T00:00:00Z